IgG1 from Myeloma Plasma (Native Human)

• Description:

  IgG1 from Myeloma Plasma (Native Human)_x000D_ Catalog number: B2016839_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mg_x000D_ Molecular Weight or Concentration: 146 kDa_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -80°C_x000D_ Keywords: Native Human IgG1 from Myeloma Plasma_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Holvoet P, Stassen JM, Hashimoto Y, Spriggs D, Devos P, Collen D. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits Thromb Haemost. 1989 Apr 25;61(2):307-13._x000D_ 2: Thürmann P, Harder S. Criteria for the appropriate drug utilisation of immunoglobulin Pharmacoeconomics. 1996 May;9(5):417-29._x000D_ 3: Wypych J, Li M, Guo A, Zhang Z, Martinez T, Allen MJ, Fodor S, Kelner DN, Flynn GC, Liu YD, Bondarenko PV, Ricci MS, Dillon TM, Balland A. Human IgG2 antibodies display disulfide-mediated structural isoforms J Biol Chem. 2008 Jun 6;283(23):16194-205._x000D_ 4: Thürmann PA, Sonnenburg C, Valentová K, Gregora E, Freischläger F, Lissner R. Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma Eur J Clin Pharmacol. 2001 Jun;57(3):235-41._x000D_ 5: Horton HM, Bernett MJ, Peipp M, Pong E, Karki S, Chu SY, Richards JO, Chen H, Repp R, Desjarlais JR, Zhukovsky EA. Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies Blood. 2010 Oct 21;116(16):3004-12._x000D_ 6: Ishida T. Therapeutic antibodies for multiple myeloma Jpn J Clin Oncol. 2018 Nov 1;48(11):957-963._x000D_ 7: Abramson N, Shattil SJ. M-components JAMA. 1973 Jan 8;223(2):156-9._x000D_ 8: Yang EH, Muhsen IN, Samarkandi H, El Fakih R, Aljurf M, Hanbali A. Role of Anti-CD38 Monoclonal Antibodies in the Treatment of Adult Immune Hematological Diseases Hematol Oncol Stem Cell Ther. 2023 Jul 20;17(1):4-12._x000D_ 9: Kwan JY. Paraproteinemic neuropathy Neurol Clin. 2007 Feb;25(1):47-69._x000D_ 10: Mellstedt H, Hammarström S, Holm G. Monoclonal lymphocyte population in human plasma cell myeloma Clin Exp Immunol. 1974 Jul;17(3):371-84._x000D_ _x000D_ Products Related to IgG1 from Myeloma Plasma (Native Human) can be found at Proteins

• Short Description:

  Catalog Number: B2016839 (1 mg)_x000D_ IgG1 from Myeloma Plasma (Native Human) is a high quality specific type of immunoglobulin G1 (IgG1) antibody that is naturally produced by plasma cells derived from a patient with multiple myeloma. IgG1 is one of the subclasses of immunoglobulin G antibodies found in humans, and it plays a crucial role in the immune system by recognizing and binding to specific antigens, such as pathogens or foreign substances. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5